NOS2 and Sepsis: Given the proven action of inducible nitric oxide synthase inhibitors in targeting mitochondria and reducing oxidative damage in severe sepsis [80], similar to what has been already observed for cardiorenal syndrome type 1 [81], the identification of post-transcriptional modification and amino acid modification could represent an interesting avenue of research for future sepsis biomarkers.